| Title： | Rapid Advice Guideline for Precision Therapy of P2Y12 Receptor Antagonists |
| Edition： | Original |
| Classification： | Rapid advice guideline |
| Field： | Treatment |
| Countries and regions： | China |
| Guidelines users： | |
| Evidence classification method： | GRADE |
| Development unit： | Beijing Anzhen Hospital, Capital Medical University |
| Registration time: | 2020-08-05 |
| Registration number： | IPGRP-2020CN107 |
| Purpose of the guideline: |
Latest registration
